<DOC>
	<DOCNO>NCT01295580</DOCNO>
	<brief_summary>The purpose study determine comparative safety efficacy knee intra-articular injection hyaluronic acid obtain two different source treatment knee osteoarthritis .</brief_summary>
	<brief_title>Comparative Study Safety Efficacy Two Hyaluronic Acids Treatment Knee Osteoarthritis</brief_title>
	<detailed_description>This multicenter , randomize , double blind , parallel-controlled clinical trial use non-inferiority comparison evaluate efficacy safety intra-articular injection Durolane® v Artz® treatment knee osteoarthritis . Subjects randomize 1:1 receive either Durolane Artz . All subject follow 26 week initial treatment.The screening period expect 2 week duration baseline visit . Each subject provide write informed consent undergo qualify screen . Assessment screen include postero-anterior view stand weight-bearing semi-flexed radiograph study knee . The OA change study knee grade 0,1,2,3 4 accord Kellgren-Lawrence radiographic score criterion . Radiographic assessment make assign well trained investigator study center . The study knee contralateral knee use Likert WOMAC 5-point scoring pain assessment . Physical examination knee vital sign perform ( examination repeat end ) .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Subject ( female male ) 4080 year age , inclusive Documented diagnosis mild moderate osteoarthritis study knee fulfil ACR ( American College Rheumatology ) criteria Radiographic evidence osteoarthritis study knee ( Kellgren Lawrence radiographic score 2 3 ) Clinically apparent tense effusion study knee examination determine either positive bulge sign positive ballottement patella KellgrenLawrence radiographic score 0 , 1 4 study knee Symptomatic osteoarthritis contralateral knee either hip responsive acetaminophen/paracetamol and/or require protocol prohibit therapy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>